We are thrilled to share wonderful news with our Neurosolve community.
Our Co-Principal Investigator (Co-PI) for the UNZA partner, Dr. Gideon Zulu, has officially been awarded his PhD in Public Health and Zoonosis.
A medical doctor specialized in public health, Dr. Zulu conducted his doctoral research in collaboration with the Department of Clinical Studies within the School of Veterinary Medicine at the University of Zambia (UNZA).
His doctoral thesis focused on:
- Epidemiology and control: how the Taenia solium parasite spreads within Zambian communities, identifying risk factors, the most affected areas, and the best strategies to prevent and contain the infection.
- Clinical characteristics and diagnosis: how the disease manifests in patients where the parasite has reached the central nervous system, causing neurocysticercosis. This includes understanding symptoms, improving diagnostic methods, and optimizing patient medical management.
By focusing on the epidemiology of Taenia solium infections in Zambia and the clinical characteristics of patients suffering from Neurocysticercosis (NCC), Dr. Zulu’s work connects directly to the core of Neurosolve’s mission through three fundamental pillars.
- Clinical data for technological innovation: Neurosolve aims to develop advanced diagnostic and monitoring tools for Neurocysticercosis in low- and middle-income countries. The real-world data collected by Dr. Zulu on the neurological and clinical manifestations of Zambian patients are essential for calibrating and validating these new technologies in the field.
- “One Health” approach: Since Taenia solium completes its life cycle by passing from humans to pigs and vice versa (often due to poor hygiene or consuming undercooked meat), Dr. Zulu’s research bridges human and veterinary medicine to block parasite transmission in the environment. By tackling the issue at its roots rather than just in the acute phase, the research fully embraces the integrated approach promoted by Neurosolve.
- From mapping to care: By identifying who gets sick, where, and how the pathology manifests within communities, the thesis aims to provide a picture of the current real-world situation. This offers vital support to Neurosolve’s efforts in bridging the diagnostic and therapeutic gap.
Gaining a deep understanding of the dynamics of these infections in endemic contexts is the first, crucial step toward developing increasingly effective prevention and eradication strategies.
Our warmest congratulations go to Dr. Zulu for leading this advancement and achieving this academic and professional milestone with dedication, passion, and scientific rigor!